secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARVARD BIOSCIENCE INC (HBIO)
CIK:        0001123494
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001171843-23-003988
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harvard Bioscience appoints Jennifer Cote as permanent CFO; $300k base salary, 50% bonus target
--------------------------------------------------------------------------------

- Jennifer Cote, previously interim CFO since January 2023, appointed permanently as CFO and Treasurer effective June 19, 2023.
- Employment agreement includes base salary of $300,000 and annual bonus target of 50% of base salary.
- Prior to HBIO, Cote held finance leadership roles at Bose Corporation and was an Audit Manager at Arthur Andersen.
- Cote is a CPA and CGMA; she joined the company as VP of Global Finance in May 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1123494/000117184323003988/0001171843-23-003988-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1123494/000117184323003988/f8k_062023.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-003988

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer